Pieracci Fredric M, Rodil Maria, Haenel James, Stovall Robert T, Johnson Jeffrey L, Burlew Clay C, Jurkovich Gregory J, Moore Ernest E
Denver Health Medical Center/University of Colorado Health Sciences Center , Department of Surgery, Denver, Colorado.
Surg Infect (Larchmt). 2015 Aug;16(4):368-74. doi: 10.1089/sur.2014.086. Epub 2015 May 28.
Refinement of criteria for both screening and initiation of empiric therapy in ventilator-associated pneumonia (VAP) will minimize antibiotic overuse. We hypothesized that variables within the commonly used Clinical Pulmonary Infection Score (CPIS) have unfavorable test performance characteristics.
Consecutive bronchoalveolar lavage (BAL) cultures obtained from surgical intensive care unit patients were abstracted (2009-2012). Ventilator-associated pneumonia was defined as ≥10(5) cfu/mL. The CPIS both without (CPISclinical) and with (CPISclinical+GS) the result of gram stain (GS) was calculated. Test performance characteristics for the sample, as well as several subgroups, were compared.
One thousand thirteen lower respiratory tract cultures from 492 patients were analyzed; 438 (43.2%) of cultures were classified as VAP, and 310 of 492 patients (62.4%) had ≥1 episode of VAP. Both CPISclinical and CPISclinical+GS had poor discrimination for VAP (Receiver-operating characteristic area under the curve=0.55 and 0.66, respectively). Sensitivity of CPISclinical using a threshold of >6 was 21%; the lowest threshold for CPISclinical for which the sensitivity was at least 85% was 3. The highest sensitivity among the individual CPIS components was new CXR infiltrate (91.1%). Among the subset of cultures sent during the early VAP window (days intubated 2-5), organisms on GS had a sensitivity of 93.3%. The CPISclinical, CPISclinical+GS, organisms, and neutrophils on GS parameters all became less accurate in both the late VAP window and when screening for recurrent VAP. Every case of VAP had at least one of the following: 1) fever; 2) new CXR infiltrate, or 3) organisms on GS.
In this series of BALs, traditional screening tools for VAP missed the majority of microbiological confirmed cases. Screening based on either new CXR infiltrate or fever yielded an acceptably high sensitivity. The only scenario identified in which empiric antibiotics could be withheld safely was the absence of organisms on GS in the early VAP window.
完善呼吸机相关性肺炎(VAP)的筛查标准和经验性治疗启动标准将减少抗生素的过度使用。我们推测常用的临床肺部感染评分(CPIS)中的变量具有不良的测试性能特征。
提取了外科重症监护病房患者连续的支气管肺泡灌洗(BAL)培养结果(2009 - 2012年)。呼吸机相关性肺炎定义为≥10⁵cfu/mL。计算了不包括革兰氏染色(GS)结果的CPIS(CPISclinical)和包括GS结果的CPIS(CPISclinical + GS)。比较了样本以及几个亚组的测试性能特征。
分析了来自492例患者的1013份下呼吸道培养结果;438份(43.2%)培养结果被归类为VAP,492例患者中有310例(62.4%)发生≥1次VAP。CPISclinical和CPISclinical + GS对VAP的鉴别能力均较差(曲线下面积分别为0.55和0.66)。CPISclinical以>6为阈值时的敏感性为21%;敏感性至少为85%时CPISclinical的最低阈值为3。CPIS各个组成部分中最高的敏感性是新的胸部X线浸润(91.1%)。在VAP早期窗口(插管后2 - 5天)送检的培养结果子集中,GS上的微生物敏感性为93.3%。在VAP晚期窗口以及筛查复发性VAP时,CPISclinical、CPISclinical + GS、GS上的微生物和中性粒细胞参数的准确性均降低。每例VAP至少具备以下一项:1)发热;2)新的胸部X线浸润,或3)GS上有微生物。
在这一系列BAL中,传统的VAP筛查工具遗漏了大多数微生物学确诊病例。基于新的胸部X线浸润或发热进行筛查可获得较高的敏感性。唯一确定的可以安全停用经验性抗生素的情况是在VAP早期窗口GS上没有微生物。